Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · MANNKIND CORP (MNKD)

MannKind revenue rises 43% to $109.4 million; swings to Q2 net loss of $19.0 million

Mixed Impact 3 of 5 earnings Written later

MannKind reported second quarter 2026 total revenues of $109.4 million, up 43% from $76.5 million a year earlier, driven by the Furoscix acquisition and higher collaborations and royalties. The company posted a net loss of $19.0 million, or $0.06 per share, compared with net income of $668 thousand a year earlier, as operating expenses rose sharply, including selling, general and administrative expenses of $58.3 million.

Key points

  • Q2 2026 total revenues of $109.4 million, up 43% from $76.5 million in Q2 2025
  • Net loss of $19.0 million, or $0.06 per share, versus net income of $668 thousand, or $0.00 per share, in Q2 2025
  • Furoscix net sales of $22.2 million and Afrezza net sales of $17.0 million in Q2 2026
  • Cash, cash equivalents and investments totaled $111 million as of June 30, 2026; a $50 million private placement closed July 24, 2026

The filing

CompanyMANNKIND CORP (MNKD)
Form8-K, current report
Filed with the SECAug 5, 2026, 4:03 PM ET
Accession number0001193125-26-335016

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:28 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 05, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.